Novavax
NVAX
NVAX
222 hedge funds and large institutions have $417M invested in Novavax in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 54 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
13% less call options, than puts
Call options by funds: $87.5M | Put options by funds: $101M
23% less capital invested
Capital invested by funds: $540M → $417M (-$124M)
44% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 52
Holders
222
Holding in Top 10
1
Calls
$87.5M
Puts
$101M
Top Buyers
| 1 | +$46.2M | |
| 2 | +$32.5M | |
| 3 | +$15.9M | |
| 4 |
Coatue Management
New York
|
+$13.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.4M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$14.4M | |
| 3 | -$13.8M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$10.3M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$8.74M |